Atovaquone is a key solution in the Pharmaceutical manufacturing industry, specifically within Manufacturing of chemical drug preparations and Manufacturing of anti infective drugs.
This article explores how HEBEI GUANGXING CHEMICAL INDUSTRY CO., LTD. supports professionals with durable, high-performance products, and explains why this product is an ideal choice for businesses in these sectors.
Table of Contents
- Atovaquone Overview
- Benefits & Use Cases of Atovaquone in Manufacturing of anti infective drugs
- Cost, Maintenance & User Experience
- Sustainability & Market Trends in Pharmaceutical manufacturing
- Conclusion on Atovaquone from HEBEI GUANGXING CHEMICAL INDUSTRY CO., LTD.
Atovaquone Overview
Atovaquone is a hydroxynaphthoquinone active pharmaceutical ingredient (API) widely used in the manufacturing of anti infective drugs, notably for protozoal infections. In the Manufacturing of chemical drug preparations, this API is valued for its selectivity and established clinical use in combination therapies. Key technical attributes include: CAS No. 95233-18-4, molecular formula C22H19ClO3, and molecular weight ≈ 366.84 g/mol. Owing to its low aqueous solubility, high-purity Atovaquone is commonly offered in micronized grades to support bioavailability in oral suspensions and solid-dosage forms, with tight particle-size distribution to ensure robust content uniformity and dissolution performance during scale-up.
HEBEI GUANGXING CHEMICAL INDUSTRY CO., LTD. supplies Atovaquone with rigorous quality controls aligned to cGMP expectations and the needs of global B2B manufacturers. Typical documentation packages include CoA, TDS, MSDS, and validated analytical methods, alongside stability data generated under ICH conditions. For partners prioritizing rapid tech transfer, our process consistency and method reproducibility help compress development timelines and reduce manufacturing variability from pilot to commercial scale.
Benefits & Use Cases of Atovaquone in Manufacturing of anti infective drugs
In anti infective manufacturing, Atovaquone is formulated for indications where protozoal control is required, including use in combination products. From a process standpoint, it is well-suited to oral suspension platforms and film-coated tablets, where finely controlled micronization, wet milling, or surfactant-based dispersion strategies are critical. Manufacturers benefit from an API that supports consistent CQAs such as assay, related substances, PSD (e.g., D90 control), and low residual solvents—key to meeting stringent release and stability specifications.
HEBEI GUANGXING CHEMICAL INDUSTRY CO., LTD. differentiates its Atovaquone by delivering:
- High purity with tight impurity profiles to minimize downstream purification and reduce OOS risk.
- Micronized and custom PSD options that enhance formulation robustness and scale-up reproducibility.
- Reliable lead times, flexible MOQs, and batch-to-batch consistency for resilient supply chains.
- Strong technical support for process development, including analytical method guidance and compatibility insights.
Our expertise in anti infective APIs, coupled with strict in-process controls, helps B2B manufacturers reduce variability, accelerate regulatory submissions, and streamline commercialization of Atovaquone-containing products.
Cost, Maintenance & User Experience
Total cost of ownership for Atovaquone is driven by quality consistency, yield, rework avoidance, and supply assurance. HEBEI GUANGXING CHEMICAL INDUSTRY CO., LTD. optimizes these levers through controlled crystallization, impurity management, and PSD uniformity that reduces blending and milling time. Customers report fewer deviation investigations and smoother tech transfers—benefits that translate into lower COGs and faster cycle times.
Practical “maintenance” considerations for this API include light protection, dry storage, and temperature control to preserve stability and PSD integrity throughout the product lifecycle. We offer robust packaging (e.g., double PE liners within fiber drums) and clear handling guidelines to minimize agglomeration and ensure consistent downstream processing. Long-term agreements, safety-stock options, and forecast-driven planning further increase ROI by reducing stockouts and expediting batch release. Feedback from pharmaceutical partners highlights a favorable balance of price competitiveness and quality performance, enabling confident scale-up from clinical to commercial supply without costly reformulations.
Sustainability & Market Trends in Pharmaceutical manufacturing
The anti infective segment continues to prioritize quality-by-design, data integrity, and resilient sourcing. Regulatory expectations (ICH Q7, Q3A/B, Q3C, Q1A) and evolving risk assessments are pushing API producers toward deeper process understanding and greener chemistry. For Atovaquone, solvent optimization, solvent recovery, and energy-efficient drying can meaningfully reduce E-factors and carbon footprint, while digital batch records improve traceability and audit readiness across global markets.
HEBEI GUANGXING CHEMICAL INDUSTRY CO., LTD. is committed to eco-conscious operations and continuous improvement. We invest in emissions control, closed-loop solvent recovery, waste minimization, and responsible packaging practices aligned to ISO-driven management systems. Our forward-looking approach—combining process intensification with rigorous EHS compliance—positions us as a dependable long-term partner for companies scaling Atovaquone portfolios while meeting corporate sustainability targets and regulatory scrutiny.
Conclusion on Atovaquone from HEBEI GUANGXING CHEMICAL INDUSTRY CO., LTD.
Atovaquone remains a high-impact API in Pharmaceutical manufacturing, especially within the Manufacturing of chemical drug preparations and Manufacturing of anti infective drugs. With high purity, customizable PSD, reliable lead times, and strong technical support, HEBEI GUANGXING CHEMICAL INDUSTRY CO., LTD. delivers the quality and consistency B2B decision makers require to de-risk development and scale commercial supply. Choose a partner focused on compliance, sustainability, and operational excellence.
- Contact us: email: admin@hbgxchemical.com
- Visit our website: https://www.hbgxchemical.com
Hebei Guangxing Chemical Co., Ltd. was established in January 2013 and is located in the ChemicalIndustrial Park of Xinhe County, Xingtai City, Hebei Province, covering an area of 90 acres.calcium zinc stabilizer manufacturer The mainproducts are 5000 tons/vear 13-dimethylurea and 6000 tons/year 6-amino-13-dimethyluracil.Hebei Guangxing Chemical Co., Ltd. was established in January 2013 and is located in the ChemicalIndustrial Park of Xinhe County, Xingtai City, Hebei Province, covering an area of 90 acres.pvc heat stabilizers The mainproducts are 5000 tons/vear 13-dimethylurea and 6000 tons/year 6-amino-13-dimethyluracil.uracils|super blog